Fig. 1From: Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumabProfile of the randomized controlled trial. Patients were divided into three cohorts: patients with surgically unsalvageable tumors (Cohort I), patients with surgically salvageable tumors (Cohort II), and patients rolled over from a previous study (Cohort III)Back to article page